NASDAQ · BMRA

Biomerica, Inc.

U.S. listed stock · USD15-minute delay

All markets

Find an instrument

Loading price chart…

Price chart by TradingView

15-minute delay. Chart times and available timeframes are controlled by the provider.

Earnings

Earnings calendar

The next earnings date for BMRA has not been announced yet.

Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.

News

RTTNews · Quiver Quantitative

RTTNews · Sep 2, 5:32 AM EDTBiomerica Posts Narrower Q4 Loss On Higher Sales; Stock Down(RTTNews) – Biomerica, Inc. (BMRA), a biomedical technology company that develops diagnostic and therapeutic products, reported its financial results for the fourth quarter, reflecting a narrower net loss and revenue growth. Meanwhile, revenue declined for fiscal 2026.
RTTNews · Aug 27, 9:16 AM EDTBiomerica Announces $2.23 Mln Private Placement; Taps B. Riley For Strategic Review(RTTNews) – Biomerica, Inc. (BMRA), a developer and manufacturer of diagnostic test systems, announced on Thursday that it has entered into definitive agreements with institutional and individual investors to generate approximately $2.23 million in gross proceeds.
RTTNews · May 29, 10:14 AM EDTBiomerica Enters Service Agreement To Develop IVD Assays(RTTNews) – Biomerica, Inc. (BMRA), a biomedical company and provider of Contract Development and Manufacturing Organization (CDMO) services for healthcare market, has entered into a Master Services Agreement or MSA with a private life science company to develop proprietary in vi
RTTNews · Apr 14, 1:59 AM EDTBiomerica Q3 Revenue Slips(RTTNews) – Biomerica, Inc. (BMRA), a biomedical technology company, reported financial results for the third quarter of fiscal year 2026, which ended on February 28, 2026, reflecting a decline in revenue.
RTTNews · Mar 18, 10:55 AM EDTBiomerica Receives First Commercial Order For HP Detect In Europe; Stock Up(RTTNews) – Biomerica, Inc. (BMRA), a biomedical technology firm, announced that it has received its first commercial order for Hp Detect, its diagnostic tool, from one of the largest clinical laboratory chains operating across Europe. The firm believes this order to have repeat
RTTNews · Jan 14, 6:30 PM ESTBiomerica, Inc. Q2 Loss Widens(RTTNews) – Biomerica, Inc. (BMRA) announced earnings for its second quarter that Increased from the same period last year
RTTNews · Dec 11, 9:09 AM ESTBiomerica Gains Egyptian Authorization For Full Portfolio Of Rapid Diagnostic Tests(RTTNews) – Biomerica, Inc. (BMRA), a provider of advanced diagnostic solutions, announced on Thursday that the Egyptian Drug Authority (EDA) has granted authorization for its complete portfolio of rapid tests for conditions related to cancers and chronic diseases.
RTTNews · Sep 3, 8:30 AM EDTBiomerica: United Arab Emirates Ministry Of Health And Prevention Approves Fortel Kidney Test(RTTNews) – Biomerica, Inc. (BMRA) announced that the United Arab Emirates Ministry of Health and Prevention has approved its Fortel Kidney Test for home use. The Fortel Kidney Test is a rapid, 10-minute easy to use diagnostic test that detects low levels of albumin in urine, a c
RTTNews · Jul 2, 2:29 PM EDTBiomerica Secures PLA Code For InFoods IBS Test, Advancing Reimbursement Access(RTTNews) – Biomerica, Inc. (BMRA), a global biomedical firm specializing in gastroenterology diagnostics, announced that its inFoods IBS test has been granted a Proprietary Laboratory Analysis – PLA code by the American Medical Association's CPT Editorial Panel.
Quiver Quantitative · Jul 2, 8:13 AM EDTBiomerica, Inc. Secures PLA Code for inFoods® IBS Test to Enhance Patient Access and Insurance ReimbursementBiomerica's inFoods® IBS test receives a PLA code, enhancing reimbursement access and personalized treatment for IBS symptoms.
Quiver Quantitative · Jun 26, 8:30 AM EDTBiomerica Inc. Appoints Scott Madel as Chief Commercial Officer to Drive Growth of inFoods® IBSScott Madel appointed Chief Commercial Officer at Biomerica, focusing on expanding commercialization of inFoods® IBS solutions.
Quiver Quantitative · Jun 6, 9:40 AM EDTBiomerica, Inc. Appoints Eric B. Chin to Board of Directors to Enhance Financial OversightBiomerica appoints Eric B. Chin to its Board of Directors, enhancing corporate governance and financial oversight.

Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.

Company profile

Loading company profile…

Company profile by TradingView

Financials

Loading fundamental data…

Fundamental data by TradingView

More headlines

More stories for Biomerica, Inc. from TradingView. Coverage varies.

Loading related news…